BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6283175)

  • 1. Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutant.
    Larder BA; Darby G
    J Virol; 1982 May; 42(2):649-58. PubMed ID: 6283175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
    Darby G; Field HJ; Salisbury SA
    Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
    Larder BA; Derse D; Cheng YC; Darby G
    J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
    PalĂș G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
    Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Fyfe JA; McKee SA; Keller PM
    Mol Pharmacol; 1983 Sep; 24(2):316-23. PubMed ID: 6310366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 8. Cooperative effects between two acyclovir resistance loci in herpes simplex virus.
    Darby G; Churcher MJ; Larder BA
    J Virol; 1984 Jun; 50(3):838-46. PubMed ID: 6328014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1.
    Larder BA; Cheng YC; Darby G
    J Gen Virol; 1983 Mar; 64 Pt 3():523-32. PubMed ID: 6298344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus.
    Field HJ; Darby G; Wildy P
    J Gen Virol; 1980 Jul; 49(1):115-24. PubMed ID: 6252285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 14. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
    Furman PA; Coen DM; St Clair MH; Schaffer PA
    J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in substrate specificity and physicochemical properties of deoxythymidine kinase of a drug-resistant herpes simplex virus type 1 mutant.
    Veerisetty V; Gentry GA
    J Virol; 1983 Jun; 46(3):901-8. PubMed ID: 6304349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir-resistant, pathogenic herpesviruses.
    Coen DM
    Trends Microbiol; 1994 Dec; 2(12):481-5. PubMed ID: 7889324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
    Besecker MI; Furness CL; Coen DM; Griffiths A
    J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis.
    Crumpacker CS; Chartrand P; Subak-Sharpe JH; Wilkie NM
    Virology; 1980 Aug; 105(1):171-84. PubMed ID: 6251603
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy.
    Burns WH; Saral R; Santos GW; Laskin OL; Lietman PS; McLaren C; Barry DW
    Lancet; 1982 Feb; 1(8269):421-3. PubMed ID: 6121091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.